FTC to reverse policies supporting pharmacy benefit managers

The US Federal Trade Commission is reversing years of prior advocacy in support of pharmacy benefit managers amid increased scrutiny of the controversial role these companies play in the pharmaceutical supply chain. Yesterday, the agency said it will issue a statement “cautioning against reliance” on previous advocacy statements.